NCT03458689

Brief Summary

The enhanced recovery after surgery and laparoscopic approach have been proven beneficial in surgery of the colon. However, patients have still pain, nausea and vomiting postoperatively. Postoperative pain is an expected but undesirable effect after an operation. This study will compare Transabdominis Plane (TAP) Block and Quadratus Lumborum (QL) Block with the common postoperative treatment with enteral and parenteral analgesics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

February 28, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 8, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

2.8 years

First QC Date

February 28, 2018

Last Update Submit

March 12, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Use of analgesics - "change" is being assessed

    Amount of analgesics used postoperative

    1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)

Secondary Outcomes (6)

  • Pain at the incision site - "change" is being assessed

    1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)

  • Deep pain and pain on coughing - "change" is being assessed

    1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)

  • Nonsteroidal anti-inflammatory drug consumption - "change" is being assessed

    1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)

  • Postoperative nausea and vomiting - "change" is being assessed

    1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)

  • Antiemetic administered - "change" is being assessed

    1 week (0-4 hrs) (4-24 hrs) (24-48 hrs) (48 - 168 hrs)

  • +1 more secondary outcomes

Study Arms (3)

Left hemicolectomy without nerve blocks

OTHER

Left hemicolectomy, laparoscopic technique Enteral and parenteral analgesics such as paracetamol and oksykodon

Procedure: Left hemicolectomy, laparoscopic technique

Left hemicolectomy with TAP block

ACTIVE COMPARATOR

Left hemicolectomy, laparoscopic technique TAP block bilateral with Naropin 3,75 mg/ml, 2 x 20 ml

Procedure: Left hemicolectomy, laparoscopic technique

Left hemicolectomy with QL block

ACTIVE COMPARATOR

Left hemicolectomy, laparoscopic technique QL block bilateral with Naropin 3,75 mg/ml, 2 x 20 ml

Procedure: Left hemicolectomy, laparoscopic technique

Interventions

Left hemicolectomy, Laparoscopic technique

Also known as: QL block bilateral with ropivacain 3,75 mg/ml (2 x 20 ml), TAP block with ropivacain 3,75 mg/ml (2 x 20 ml), Traditional analgesics such as paracetamol and oksycodon
Left hemicolectomy with QL blockLeft hemicolectomy with TAP blockLeft hemicolectomy without nerve blocks

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-80 Years
  • BMI 20-35
  • ASA physical status I-II

You may not qualify if:

  • Allergy to LA
  • Chronic pain requiring opioid analgesics
  • Patients with atrioventricular block II
  • Patients treated with class III antiarrhythmics
  • Patients with severe renal and/or hepatic disease
  • A coagulation disorder
  • An infection at the LA injection place

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ostfold Hospital Trust, Moss

Grålum, Østfold fylke, 1714, Norway

RECRUITING

Related Publications (6)

  • Borglum J, Gogenur I, Bendtsen TF. Abdominal wall blocks in adults. Curr Opin Anaesthesiol. 2016 Oct;29(5):638-43. doi: 10.1097/ACO.0000000000000378.

  • Blanco R, Ansari T, Riad W, Shetty N. Quadratus Lumborum Block Versus Transversus Abdominis Plane Block for Postoperative Pain After Cesarean Delivery: A Randomized Controlled Trial. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):757-762. doi: 10.1097/AAP.0000000000000495.

  • El-Dawlatly AA, Turkistani A, Kettner SC, Machata AM, Delvi MB, Thallaj A, Kapral S, Marhofer P. Ultrasound-guided transversus abdominis plane block: description of a new technique and comparison with conventional systemic analgesia during laparoscopic cholecystectomy. Br J Anaesth. 2009 Jun;102(6):763-7. doi: 10.1093/bja/aep067. Epub 2009 Apr 17.

  • Murouchi T, Iwasaki S, Yamakage M. Quadratus Lumborum Block: Analgesic Effects and Chronological Ropivacaine Concentrations After Laparoscopic Surgery. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):146-50. doi: 10.1097/AAP.0000000000000349.

  • Pirrera B, Alagna V, Lucchi A, Berti P, Gabbianelli C, Martorelli G, Mozzoni L, Ruggeri F, Ingardia A, Nardi G, Garulli G. Transversus abdominis plane (TAP) block versus thoracic epidural analgesia (TEA) in laparoscopic colon surgery in the ERAS program. Surg Endosc. 2018 Jan;32(1):376-382. doi: 10.1007/s00464-017-5686-7. Epub 2017 Jul 1.

  • Ueshima H, Otake H, Lin JA. Ultrasound-Guided Quadratus Lumborum Block: An Updated Review of Anatomy and Techniques. Biomed Res Int. 2017;2017:2752876. doi: 10.1155/2017/2752876. Epub 2017 Jan 3.

MeSH Terms

Conditions

Colonic NeoplasmsPain, Postoperative

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Jan Sverre Vamnes, MD, Ph.D.

    Senior Consultant

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jan Sverre Vamnes, MD, Ph.D.

CONTACT

Klaus Risnes, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Information connecting the patients to the data are kept locked and will be destroyed after the end of the investigation
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior conultant, Ph.D.

Study Record Dates

First Submitted

February 28, 2018

First Posted

March 8, 2018

Study Start

February 28, 2018

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

March 13, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations